智通财经APP讯，通达集团(00698)发布公告，于2025年12月30日及2026年2月12日，本公司间接非全资 附属公司通达创智(厦门)及通达创智(石狮)利用其闲置资金认购若干理财产品，包括认购(i)第一项兴业 银行理财产品、第二项兴业银行理财产品、第三项兴业银行理财产品及第四项兴业银行理财产品，认购 金额分别为人民币1400万元、人民币1800万元、人民币4500万元及人民币1700万元。 ...

通达集团(00698)发布公告，于2025年12月30日及2026年2月12日，本公司间接非全资附属公司通达创智 （001368）(厦门)及通达创智(石狮)利用其闲置资金认购若干理财产品，包括认购(i)第一项兴业银行理 财产品、第二项兴业银行理财产品、第三项兴业银行理财产品及第四项兴业银行理财产品，认购金额分 别为人民币1400万元、人民币1800万元、人民币4500万元及人民币1700万元。 ...

格隆汇2月12日丨通达集团(00698.HK)公告，于2025年12月30日及2026年2月12日，公司间接非全资附属 公司通达创智(厦门)及通达创智(石狮)利用其闲置资金认购若干理财产品，包括认购(i)第一项兴业银行 理财产品、第二项兴业银行理财产品、第三项兴业银行理财产品及第四项兴业银行理财产品，认购金额 分别为人民币1400万元、人民币1800万元、人民币4500万元及人民币1700万元。 ...

格隆汇2月12日丨通达集团(00698.HK)公告，于2025年12月30日及2026年2月12日，公司间接非全资附属 公司通达创智(厦门)及通达创智(石狮)利用其闲置资金认购若干理财产品，包括认购(i)第一项兴业银行 理财产品、第二项兴业银行理财产品、第三项兴业银行理财产品及第四项兴业银行理财产品，认购金额 分别为人民币1400万元、人民币1800万元、人民币4500万元及人民币1700万元。 ...

Core Viewpoint - Tongda Group (00698) announced that its indirect non-wholly owned subsidiaries, Tongda Chuangzhi (001368) in Xiamen and Tongda Chuangzhi in Shishi, will utilize idle funds to subscribe to several wealth management products from Industrial Bank [1] Summary by Category - **Investment Amounts** - The subscription amounts for the wealth management products are as follows: RMB 19 million, RMB 8 million, RMB 18 million, and RMB 4 million [1] - **Wealth Management Products** - The company is subscribing to four different wealth management products from Industrial Bank [1]

Core Viewpoint - Tongda Group (00698) announced the investment of idle funds into various financial products from Industrial Bank, indicating a strategic move to optimize asset management and enhance returns [1] Group 1: Investment Details - The company’s indirect non-wholly owned subsidiaries, Tongda Chuangzhi (Xiamen) and Tongda Chuangzhi (Shishi), will subscribe to several financial products [1] - The amounts invested in the financial products are as follows: RMB 19 million, RMB 8 million, RMB 18 million, and RMB 4 million respectively [1]

Core Viewpoint - Tongda Group (00698.HK) announced the subscription of various financial products using idle funds by its indirect non-wholly owned subsidiaries, Tongda Chuangzhi (Xiamen) and Tongda Chuangzhi (Shishi) [1] Summary by Category - **Investment Details** - The company subscribed to several financial products from Industrial Bank, with amounts of RMB 19 million, RMB 8 million, RMB 18 million, and RMB 4 million respectively for the first, second, third, and fourth products [1]

Core Viewpoint - Tianjin Development (00882.HK) announced the signing of the eleventh wealth management agreement with Xingyin Wealth Management and Industrial Bank, involving a principal amount of RMB 30 million for subscribing to another fixed-income investment product [1] Group 1 - The agreement was established on November 19, 2025, indicating a future investment strategy [1] - The investment amount of RMB 30 million is approximately USD 4.2 million, reflecting the company's commitment to diversifying its investment portfolio [1]

Core Viewpoint - Tianjin Development (00882) has announced an investment of RMB 30 million (approximately HKD 32.82 million) in a fixed-income investment product through its indirect non-wholly owned subsidiary, Lifescience Pharmaceutical, in collaboration with Industrial Bank and its wealth management division [1] Group 1 - The investment agreement is the eleventh of its kind between Lifescience Pharmaceutical and Industrial Bank [1] - The transaction is set to take place on November 19, 2025 [1]

Core Viewpoint - Tianjin Development (00882) announced a new investment agreement involving its indirect non-wholly owned subsidiary, Lifesun Pharmaceutical (002393), which will invest in a fixed-income product through a financial agreement with Xingyin Wealth Management and Industrial Bank [1] Group 1 - Lifesun Pharmaceutical has entered into its eleventh financial agreement with Industrial Bank, committing a principal amount of RMB 30 million, equivalent to approximately HKD 32.82 million [1]